Search
Flurothyl
go.drugbank.com/drugs/DB08969ApprovedWithdrawnFlurothyl is a convulsant primarily used in experimental animals. It was formerly used to induce convulsions as a alternative to electroshock therapy.
Fluocortolone
go.drugbank.com/drugs/DB08971ApprovedWithdrawnFluocortolone is a glucocorticoid with anti-inflammatory activity used topically for various skin disorders.
Fluclorolone acetonide
go.drugbank.com/drugs/DB08973ApprovedWithdrawnFluclorolone acetonide (INN) or flucloronide (USAN) is a topical corticosteroid. It is marketed under the brand names Cutanit and Topicon.
Fenspiride
go.drugbank.com/drugs/DB08979InvestigationalFenspiride is an oxazolidinone spiro compound used as a drug in the treatment of certain respiratory diseases.
Ethoheptazine
go.drugbank.com/drugs/DB08988ApprovedWithdrawnIt is a phenazepine based opioid analgesic. It was invented in the 1950s and is related to other drugs such as proheptazine. Ethoheptazine is no longer marketed in the United States.
Dimetacrine
go.drugbank.com/drugs/DB08996ApprovedWithdrawnDimetacrine is a tricyclic antidepressant (TCA) with imipramine-like effects used in Europe for the treatment of depression. Dimetacrine is no longer used in Japan.
Batroxobin
go.drugbank.com/drugs/DB09005InvestigationalBatroxobin is a defibrinogenating hemostatic agent derived from the venom of a pit viper, Bothrops atrox moojeni. … Batroxobin will also bind fibrinogen in a manner different than thrombin and with a higher affinity.
International brands: Su Le Juan, Ba Qu TingCategories: Venombin AClinofibrate
go.drugbank.com/drugs/DB09006ExperimentalClinofibrate is a fibrate drug sold and marketed in Japan.
Carbazochrome
go.drugbank.com/drugs/DB09012ApprovedWithdrawneither at a local or systemic level [A19744]. … It is not FDA-approved but is available as tablets or IM/SC injections in the treatment of hemorrhages in a number of countries.
International brands: Di Ka Ning, Su Bo TeBefunolol
go.drugbank.com/drugs/DB09013ExperimentalBefunolol is a beta blocker introduced in 1983 by Kakenyaku Kakko. It is currently in experimental status, and is being tested for the management of open angle glaucoma.